Therapy News and Research

RSS

Steady points to need for more rigorous evaluation of complementary & alternative medicine use

In a comparison of complementary and alternative medicine (CAM) use by adults in 1997 and 2002, researchers from Harvard Medical School found more than one in three U.S. adults (36.5 and 35.0 percent, respectively) used at least one form of CAM.

12 Jan 2005

Researchers to test new leukemia drug

Chronic myeloid leukemia (CML) is a malignant cancer of the blood that affects people of all ages. While treatment is available for most of these patients, approximately 20 percent of them do not respond to it. Researchers at McGill teaching hospitals will soon study the effects of a new alternative therapy.

12 Jan 2005

Research breakthrough in treatment of TB and MDR-TB

FASgen Inc.'s compound, FAS20013, has emerged from an intense multi-year program of pre-clinical studies that clearly validate its potential as an ideal new drug for the treatment of tuberculosis and MDR-TB, the disease caused by organisms that are resistant to the drugs now commonly used to treat TB. Initial clinical trials in both TB and MDR-TB are scheduled for later this year.

12 Jan 2005

Amarin announces positive results from studies using Miraxion to treat unresponsive depression

Amarin Corporation today announced positive data analysis from two exploratory phase IIa clinical studies using Miraxion (formerly referred to as LAX-101c) to treat depression.

12 Jan 2005

Screening for malaria necessary for U.S. soldiers returning from Afghanistan

Nearly 40 U.S. Army Rangers returning from Afghanistan in 2002 may have contracted malaria because of inadequate use of preventive measures, according to a study in the January 12 issue of JAMA.

12 Jan 2005

Important clue to understanding the origins of the AIDS epidemic

Medical Research Council (MRC) scientists have uncovered an important clue to understanding the origins of the AIDS epidemic. The work suggests that harnessing natural mechanisms of resistance to HIV infection might provide new methods for combating AIDS.

12 Jan 2005

Campral, first new treatment for alcoholism in ten years

Forest Laboratories announced that Campral (acamprosate calcium) Delayed- Release Tablets are now available to physicians, patients and pharmacies nationwide.

12 Jan 2005

Corticosteroids can be beneficial in the treatment of Duchenne muscular dystrophy

Corticosteroids can be beneficial in the treatment of Duchenne muscular dystrophy and can be offered as a treatment option, according to the American Academy of Neurology and the Child Neurology Society in a new practice guideline published in the January 11 issue of Neurology, the scientific journal of the American Academy of Neurology.

10 Jan 2005

Patient education on aerosol therapy key to effective asthma control

New evidence-based guidelines for the selection of aerosol medication devices conclude that health-care providers should avoid basing device selection exclusively on device efficacy. Instead, the choice should be based on other patient-related factors.

10 Jan 2005

Modafinil may be a possible medicinal treatment for cocaine dependence

Cocaine dependence is a major public health problem affecting thousands of people around the globe. Despite years of active research there are still no approved medications for the treatment of this life-shattering addiction.

10 Jan 2005

New portable infectious disease detector

A portable device similar to today's home pregnancy tests that can quickly detect the presence of infectious diseases, including HIV-AIDS and measles, as well as biological agents such as ricin and anthrax, is the object of a new joint university/industry research project.

10 Jan 2005

Important clue to understanding the origins of the AIDS epidemic

10 Jan 2005

Scientists examine the role of small sputum macrophages in the widespread disease chronic obstructive bronchitis

COPD (chronic obstructive pulmonary disease) is one of the most common fatal diseases worldwide. In Germany alone, there are about 3-5 million patients affected. COPD includes both chronic obstructive bronchitis and emphysema. Both represent irreversible changes of the central and lower respiratory tract which are accompanied by coughing, mucus production and difficulty in breathing.

10 Jan 2005

Potential new therapies for cancer and bleeding disorders

Lexicon Genetics announced today that it has advanced two of its drug discovery programs into preclinical development in preparation for investigational new drug (IND) applications.

10 Jan 2005

Idiopathic pulmonary fibrosis study points to survival as key endpoint in future actimmune studies

InterMune, Inc. today announced that CHEST, the journal of the American College of Chest Physicians, published an important analysis of variables that measure clinical outcomes in patients with idiopathic pulmonary fibrosis (IPF), a deadly and debilitating lung disease.

10 Jan 2005

Velcade (bortezomib) phase III clinical trial initiated in patients with newly diagnosed multiple myeloma

Millennium Pharmaceuticals today announced, in collaboration with Johnson & Johnson Pharmaceutical Research & Development, LLC, the initiation of VISTA (Velcadeas Initial Standard Therapy in multiple myeloma: Assessment with melphalan and prednisone), a multicenter, international phase III clinical trial of Velcadein combination with melphalan and prednisone versus melphalan and prednisone in patients with newly diagnosed multiple myeloma (MM) who are not transplant candidates.

10 Jan 2005

Ranbaxy files anti-retrovirals (ARVs) to the U.S. FDA

Ranbaxy Laboratories Limited (Ranbaxy) announced today that the Company has so far made three filings of its Anti-Retrovirals (ARVs) to the U.S. FDA for its approval under the expedited review process of the President's Emergency Plan for AIDS Relief (PEPFAR).

10 Jan 2005

Therapy News and Research

Steady points to need for more rigorous evaluation of complementary & alternative medicine use

Researchers to test new leukemia drug

Research breakthrough in treatment of TB and MDR-TB

Amarin announces positive results from studies using Miraxion to treat unresponsive depression

Screening for malaria necessary for U.S. soldiers returning from Afghanistan

Important clue to understanding the origins of the AIDS epidemic

Campral, first new treatment for alcoholism in ten years

Corticosteroids can be beneficial in the treatment of Duchenne muscular dystrophy

Patient education on aerosol therapy key to effective asthma control

Modafinil may be a possible medicinal treatment for cocaine dependence

New portable infectious disease detector

Important clue to understanding the origins of the AIDS epidemic

Scientists examine the role of small sputum macrophages in the widespread disease chronic obstructive bronchitis

Potential new therapies for cancer and bleeding disorders

Idiopathic pulmonary fibrosis study points to survival as key endpoint in future actimmune studies

Velcade (bortezomib) phase III clinical trial initiated in patients with newly diagnosed multiple myeloma

Ranbaxy files anti-retrovirals (ARVs) to the U.S. FDA

Serono announces the availability of Saizen for adult growth hormone deficiency

Body drumming a hit for phobics

Statins lower C-reactive protein (CRP), a major new risk factor for heart disease marked by inflammation

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News